Apropos Bhupesh Bhandari's article, "Listen to Dinesh Thakur" (May 6), it is correct that the Indian pharmaceutical sector makes the finest medicines in the world, but sells substandard products to Indians. Ranbaxy whistle-blower Thakur has said that Indian companies regularly recall their products from the United States and the European Union.
What intrigues the Indian consumer is what happens to the millions of formulations that are recalled. Are they disposed of, like Nestle did during the Maggi imbroglio? Are they redistributed in India? The drugs controller and the pharmaceutical industry should assure the public that Indians, too, receive drugs of consistent quality like the US and Europe and that recalled batches are not recycled into the Indian market.
H N Ramakrishna, Bengaluru
Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201 · E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
